National Active Surveillance Network and Pharmacogenomics of Adverse Drug Reactions in Children
Canadian Pharmacogenomics Network for Drug Safety
University of British Columbia
7,000 participants
Aug 1, 2005
OBSERVATIONAL
Conditions
Summary
The purpose of the study is (1) to identify and collect samples from children and adults who take drugs and have adverse drug reactions AND children and adults who take drugs and do not experience any adverse drug effects; (2) to determine if genetic differences between the two groups contribute to causing the adverse drug reactions; and (3) to develop patient specific drug dosing guidelines to prevent future adverse drug reactions. We also wish to compare the use of prescription drugs, medical and hospital services and vital statistics between BC participants who experience adverse drug reactions and those who do not. Study hypothesis: Genetic differences may contribute to patients' response to drugs and may be responsible for adverse drug reactions.
Eligibility
Inclusion Criteria4
- Children under 19 years who have taken drugs.
- Biological parents of children who have had an ADR.
- Patients/parents who speak and understand English (except in Quebec).
- Adults (for validation of findings in children)
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT00414115